Company Filing History:
Years Active: 2019-2023
Title: Innovations of Matthew A J Duncton
Introduction
Matthew A J Duncton is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic derivatives. With a total of four patents to his name, Duncton is recognized for his innovative approaches to drug synthesis and therapeutic applications.
Latest Patents
Duncton's latest patents include methods of synthesizing aztreonam derivatives. These patents disclose aztreonam derivatives, therapeutic methods for their use, and methods for their synthesis. The aztreonam derivatives can be administered orally, providing a bioavailable option for treatment. Another significant patent involves derivatives of relebactam and their uses. This patent outlines therapeutic methods for using these derivatives, especially in combination with β-lactam antibiotics, and includes pharmaceutical compositions suitable for oral administration.
Career Highlights
Matthew A J Duncton is currently associated with Arixa Pharmaceuticals, Inc. His work at Arixa focuses on advancing pharmaceutical innovations that address critical health challenges. Duncton's expertise in synthesizing complex drug compounds has positioned him as a key player in the pharmaceutical industry.
Collaborations
Some of Duncton's notable coworkers include Eric M Gordon and John Freund. Their collaborative efforts contribute to the innovative environment at Arixa Pharmaceuticals, fostering advancements in drug development.
Conclusion
Matthew A J Duncton exemplifies the spirit of innovation in the pharmaceutical sector. His contributions through patents and collaborative work continue to impact the field positively.